Effects of Walking Apnea At High Lung Volume on Hypoalgesia
Launched by UNIVERSIDAD REY JUAN CARLOS · Oct 9, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a specific type of breathing exercise, called walking apnea at high lung volume, affects pain sensitivity in healthy adults. The researchers want to see if taking short breaks from walking while holding your breath can help reduce pain, known as hypoalgesia. They are also looking at how this exercise impacts heart and lung function during the activity.
To participate in the trial, you need to be between 18 and 64 years old and in good health, meaning you shouldn't have any major health issues like heart or lung diseases. If you have a history of certain medical conditions, are pregnant, or are currently taking medication, you won't be eligible to join. Participants will engage in a 6-minute training session and will be monitored for their heart and breathing responses, so they can expect a supportive environment focused on their health and safety.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Asymptomatic subjects aged between 18 and 64 years.
- Exclusion Criteria:
- • Cardiovascular, respiratory, metabolic, neurological or osteomuscular signs or pathologies.
- • History of epilepsy.
- • Pregnant
- • Pharmacological treatment.
- • Participants who present any type of pain on the day of the measurements or who have frequently suffered pain during the previous 4 weeks.
About Universidad Rey Juan Carlos
Universidad Rey Juan Carlos (URJC) is a prominent academic institution located in Madrid, Spain, dedicated to advancing knowledge and research in various fields, including health sciences. With a commitment to innovation and excellence, URJC actively engages in clinical trials aimed at improving patient care and outcomes. The university's multidisciplinary approach fosters collaboration among researchers, clinicians, and industry partners, ensuring that its clinical research is grounded in scientific rigor and ethical standards. Through its robust infrastructure and expertise, Universidad Rey Juan Carlos is poised to contribute significantly to the advancement of medical research and the development of novel therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported